articleThe Journal of Clinical Endocrinology & MetabolismJan 1, 2006Closed access

Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus

MCMiao‐Pei ChenFCFu‐Mei ChungDCDao‐Ming ChangJCJack C.‐R. TsaiHHHan-Fen Huang

Pingtung Hospital · Pingtung Christian Hospital · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

Objectives

In this study we investigated whether plasma visfatin level is altered in patients with type 2 diabetes mellitus (T2DM). DESIGN AND PATIENTS: Plasma visfatin as well as adiponectin and resistin concentrations were measured through ELISA in type 2 diabetic and nondiabetic subjects.

Results

A total of 61 patients with T2DM and 59 sex- and age-matched nondiabetic subjects were studied. Plasma visfatin was found to be elevated in patients with T2DM (31.9 +/- 31.7 vs. 15.8 +/- 16.7 ng/ml, P = 0.002). In contrast, adiponectin was decreased (4.3 +/- 2.5 vs. 30.8 +/- 10.3 microg/ml, P

Citation impact

657
total citations
FWCI
40.81
Percentile
100%
References
32
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Internal medicine
  • Endocrinology
  • Adiponectin
  • Resistin
  • Medicine
  • Type 2 Diabetes Mellitus
  • Body mass index
  • Diabetes mellitus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.